DEC 06, 2016 11:00 AM PST

Expansion of Human Stem Cells in BioBLU Single-Use Vessels from Eppendorf

Sponsored by: Eppendorf, Eppendorf

Speaker

Stacey Willard, PhD
Senior Technical Application Specialist, Bioprocess
Biography
Stacey has over 15 years' experience in cell culture applications in both academia and industry. After her postdoctoral work at Johns Hopkins Medical School, she spent time at a startup drug discovery company and a large cancer institute before joining Eppendorf. As part of the Global Bioprocess Applications team at Eppendorf, she specializes in high-level problem solving for customers, training, and product development.

Abstract

DATE: December 6, 2016
TIME: 11:00am PT, 2:00pm ET

Experimentation involving human stem cells (HSCs) is one of the fastest growing fields in research and development due, in large part, to its potential for revolutionizing human disease treatment. There are multiple HSC platforms being investigated, including human mesenchymal stem cells (hMSCs) and human induced pluripotent stem cells (hiPSCs). Both have distinct advantages and disadvantages, but what they share is a bottleneck at the stage of scale-up, or the ability to produce enough cells for downstream R&D purposes. In this study, we discuss the successful growth of HSCs, both hMSC and hiPSC, in BioBLU® single-use stirred-tank bioreactors from the small (0.3 L) to bench (3 L) scale. In particular, we highlight the production of one billion hMSCs in a single bioreactor, and the culture of hiPSC at the small scale in parallel bioreactors.

Learning Objectives:

Learn about the challenges involved and the differences between culturing MSC and iPSC in bioreactors.
Learn about culturing stem cells in single-use vessels.

Expansion of Human Stem Cells in BioBLU Single-Use Vessels from Eppendorf

LOGIN